During the past decade, Polyclinique du Bois conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Polyclinique du Bois" #1 sponsor was "GCS Ramsay Santé pour l'Enseignement et la Recherche" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "LivaNova" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Polyclinique du Bois" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "DePuy Synthes" with 1 trials as a collaborator, "Edwards Lifesciences" with 1 trials as a collaborator, "European Clinical Trial Experts Network" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Polyclinique du Bois" are "Colorectal Cancer" (2 trials), "Advanced Breast Cancer" (1 trials), "Advanced Gastric Cancer" (1 trials), "Advanced Renal Cell Carcinoma" (1 trials) and "Advanced/Metastatic Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Polyclinique du Bois" in a lesser frequency.

Most popular intervention types in "Polyclinique du Bois" are "Drug" (9 trials), "Other" (7 trials), "Device" (4 trials), "Procedure" (4 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (2 trials), "Avelumab" (1 trials), "Best medical treatment" (1 trials), "Cardiac MRI" (1 trials) and "Cetrelimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Polyclinique du Bois" are 22 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Polyclinique du Bois". undefined are not yet recruiting, 9 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Polyclinique du Bois, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Polyclinique du Bois, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".